Sensus HealthcareSRTS
About: Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Employees: 35
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
113% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 8
90% more capital invested
Capital invested by funds: $9.21M [Q1] → $17.6M (+$8.34M) [Q2]
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
7% more funds holding
Funds holding: 44 [Q1] → 47 (+3) [Q2]
4.92% more ownership
Funds ownership: 15.06% [Q1] → 19.97% (+4.92%) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Yi Chen 36% 1-year accuracy 35 / 97 met price target | 51%upside $10 | Buy Reiterated | 12 Aug 2024 |
Financial journalist opinion
Based on 3 articles about SRTS published over the past 30 days
